Transplantation in Inherited, Systemic, and Metabolic Diseases

  • Eleanor D. Lederer


The population of end-stage renal disease patients continues to grow for a variety of reasons. Advances in renal replacement therapies have resulted in relaxed criteria for patient acceptance into renal failure programs. Improved medical management of nonrenal diseases such as diabetes and atherosclerosis has added to the end-stage renal disease population by allowing the emergence of progressive renal failure. Finally, more elderly patients are being added to dialysis programs as a consequence of the aging of the general population. The challenges posed by the variety of medical problems in this growing, diverse population have been met by innovative approaches to renal replacement therapy. The purpose of this chapter is to describe the experience of renal transplantation in several systemic, metabolic, and inherited conditions. Consonant with the theme of this book, the chapter will emphasize selection criteria, unique treatment techniques, and specialized follow-up considerations.


Systemic Lupus Erythematosus Multiple Myeloma Renal Transplantation Renal Replacement Therapy Kidney Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ekberg H, Persson NH, Kallen R. Persson MO: Reduced patient survival in diabetic recipients of renal transplants. Transplant Proc 26: 1759–1760, 1994.PubMedGoogle Scholar
  2. 2.
    Cheigh JS, Riggio RR, Stenzel KH, Green R, Tapia L, Schechter N, Suthamthiran M, Stubenbord WT, Rubin AL, Riehle RA: Kidney transplantation in insulin dependent diabetic patients: improved survival rehabilitation. Transplant Proc 21: 2016–2017, 1989.PubMedGoogle Scholar
  3. 3.
    Lewis RM, Janney RP, Golden DL, Kerr ND, Van Buren CT, Kerman RH, Kahan BD: Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy—five year follow-up. Transplantation 47: 266–272, 1989.PubMedCrossRefGoogle Scholar
  4. 4.
    Matas AJ, Gillingham KJ, Sutherland DER: Half-life and risk factors for kidney transplant outcome—importance of death with function. Transplantation 55: 757–761, 1993.PubMedCrossRefGoogle Scholar
  5. 5.
    Hirschl MM, Heinz G, Sunder-Plassman G, Derfler K: Renal replacement therapy in Type 2 diabetic patients: 10 years’ experience. Am J Kidney Dis 20: 564–568, 1992.PubMedGoogle Scholar
  6. 6.
    Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoort FA, Schreuder GM, Persijn GG: Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation 54: 152–158, 1992.PubMedCrossRefGoogle Scholar
  7. 7.
    McMillan MA, Briggs JD, Junor BJ: Outcome of renal replacement treatment in patients with diabetes mellitus. Br Med J 301: 540–544, 1990.CrossRefGoogle Scholar
  8. 8.
    Burke G, Esquenazi V, Charagozloo H, Roth D, Strauss J, Kyriakides S, Milgrom M, Ranjan D, Contreras N, Rosen A: Long-term results of kidney transplantation at the University of Miami. Clin Transplant 215–228, 1989.Google Scholar
  9. 9.
    Frohnert PP, Sterioff S: Twenty-five years of renal transplantation at Mayo Clinic. Clin Transplant 3: 267–274, 1989.Google Scholar
  10. 10.
    Najarian JS, Kaufman DB, Fryd DS, McHugh L, Mauer SM, Ramsay RC, Kennedy WR, Navarro X, Goetz FC, Sutherland DE: Long-term survival following kidney transplantation in 100 type I diabetic patients. Transplantation 47: 106–113, 1989.PubMedCrossRefGoogle Scholar
  11. 11.
    Lindholm A, Ohlman S, Alberchtsen D, Tufveson G, Persson H, Persson NH: The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 56: 307–315, 1993.PubMedCrossRefGoogle Scholar
  12. 12.
    Rischen Vos J, van der woude FJ, Tegzess AM, Zwinderman AH, Gooszen HC, van den Akker PJ, van Es LA: Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrol Dial Transplant 7: 433–437, 1992.PubMedGoogle Scholar
  13. 13.
    Yoon YS, Bang BK, Jin DC, Ahn SJ, Yoon JY, Park YH, Koh YB: Factors influencing long-term outcome of living-donor kidney transplantation in the cyclosporine era. Clin Transplant 6: 257–266, 1992.Google Scholar
  14. 14.
    Reissell E, Lindgren L, Tikkanen I, Ahonen J: Renal transplantations from the same kidney donor: outcome of diabetic and nondiabetic patients. Scand J Urol Nephrol 26: 403–408, 1992.PubMedCrossRefGoogle Scholar
  15. 15.
    Laskow DA, Diethelm AG, Hudson SL, Deierhoi MH, Barber WH, Barger BO, Gaston RS, Julian BA, Curtis JJ: Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham. Clin Transplant 5: 179–191, 1991.Google Scholar
  16. 16.
    Manivel C, Kyriakides P, Payne WD, Dunn DL: Renal transplant function after ten years of cyclosporine. Transplantation 53: 316–323, 1992.PubMedCrossRefGoogle Scholar
  17. 17.
    Hirschl MM, Derfler K, Heinz G, Sunder-Plassmann G, Waldhausl W: Long-term follow-up of renal transplantation in type 1 and type 2 diabetic patients. Clin Invest 70: 917–921, 1992.CrossRefGoogle Scholar
  18. 18.
    Hirschl MM, Heinz G, Sunder-Plassmann G, Derfler K: Renal replacement therapy in type 2 diabetic patients: 10 years’ experience. Am J Kidney Dis 20: 564–548, 1992.PubMedGoogle Scholar
  19. 19.
    Grenfell A, Bewick M, Snowden S, Watkins PJ, Parsons V: Renal replacement for diabetic patients: experience at King’s College Hospital 1980–1989. Q J Med 85:861–874Google Scholar
  20. 20.
    Lemmers MJ, Barry JM: Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients. Diabetes Care 14: 295–301, 1991.PubMedCrossRefGoogle Scholar
  21. 21.
    Weinrauch LA, D’Elia JA, Monaco AP, Gleason RE, Welty F, Nishan PC, Nesto RW: Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiography parameters on patient and allograft survival. Am J Med 93: 19–28, 1992.PubMedCrossRefGoogle Scholar
  22. 22.
    Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44:617–621Google Scholar
  23. 23.
    Trochu JN, Cantarovich D, Renaudeau J, Patra O, du Roscoat P, Helias J: Assessment of coronary artery disease by thallium scan in type 1 diabetic uremic patients awaiting combined pancrease and renal transplantation. Angiology 42: 302–307, 1991.PubMedCrossRefGoogle Scholar
  24. 24.
    Cottier C, Pfisterer M, Muller-Brand J, Thiel G, Burkart F: Cardiac evaluation of candidates for kidney transplantation: value of exercise radionuclide angiocardiography. Eur Heart J 11: 832–838, 1990.PubMedGoogle Scholar
  25. 25.
    Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SI, Chaitman RR: Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 65: 1459–1633, 1990.PubMedCrossRefGoogle Scholar
  26. 26.
    Brown KA, Rimmer J, Haisch C: Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 64: 1017–1021, 1989.PubMedCrossRefGoogle Scholar
  27. 27.
    Morrow CE, Schwartz JS, Sutherland DER, Simmons RL, Ferguson RM, Kjellstrand CM, Najarian JS: Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 146: 3331–3335, 1983.CrossRefGoogle Scholar
  28. 28.
    Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, Puschett JB: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81: 630–634, 1986.PubMedCrossRefGoogle Scholar
  29. 29.
    Manske CL, Wang Y, Rector T, Wilson RF, White CW: Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 340: 998–1002, 1992.PubMedCrossRefGoogle Scholar
  30. 30.
    Gill IS, Hayes JM, Hodge EE, Novick AC: Clean intermittent catheterization and urinary diversion in the management of renal transplant recipients with lower urinary tract dysfunction./Urol 148: 1397–1400, 1992.Google Scholar
  31. 31.
    Friedman EA, Cohen C, Lowder G, Laungani GB, Butt KMH: Cystopathy does not preclude successful kidney transplantation in diabetics. Kidney Int 29: 429, 1986.Google Scholar
  32. 32.
    Munda R, Schroeder TJ, Pedersen SA, Clardy CW, Wadhwa NK, Myre SA, Stephens GW, Pesce AJ, Alexander JW, First MR: Cyclosporine pharmacokinetics in pancreas transplant recipients. Transplant Proc 20:487–190, 1988.PubMedGoogle Scholar
  33. 33.
    Thomas AN, Pollard BJ: Renal transplantation and diabetic autonomic neuropathy. Can J Anaesth 36: 590–592, 1989.PubMedCrossRefGoogle Scholar
  34. 34.
    Reissell E, Yli Hankala A, Orko R, Lindgren L: Sudden cardiorespiratory arrest after renal transplantation in a patient with diabetic autonomic neuropathy and prolonged QT interval. Acta Anaesthesiol Scand 38: 406–408, 1994.PubMedCrossRefGoogle Scholar
  35. 35.
    Gavin LA: Management of diabetes mellitus during surgery. West J Med 151: 525–529, 1989.PubMedGoogle Scholar
  36. 36.
    Braun WF: Long-term complications of renal transplantation (clinical conference). Kidney Int 37: 1363–1378, 1990.PubMedCrossRefGoogle Scholar
  37. 37.
    Pirsch JD, D’Alessandro AM, Sollinger HW, Knechtle SJ, Reed A, Kalayoglu M, Beizer FO: Hyperlipidemia and transplantation: etiologic factors and therapy. J Am Soc Nephrol 2: S238 - S242, 1992.PubMedGoogle Scholar
  38. 38.
    Ong CS, Pollock CA, Caterson RJ, Mahony JF, Waugh DA, Ibels LS: Hyperlipidemia in renal transplant recipients: natural history and response to treatment. Medicine (Baltimore) 73: 215–223, 1994.CrossRefGoogle Scholar
  39. 39.
    Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B: Fracture frequency after kidney transplantation. Transplant Proc 26: 1764, 1994.PubMedGoogle Scholar
  40. 40.
    Hasslacher C, Borgholte G, Ritz E, Wahl P: Impact of hypertension on prognosis in IDDM. Diabete Metab 15: 338–342, 1989.PubMedGoogle Scholar
  41. 41.
    Vathsala A, Weinberg RS, Schoenberg L, Grevel J, Goldstein RA, Van Buren CT, Lewis RM, Kahan BD: Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 48: 37–43, 1989.PubMedCrossRefGoogle Scholar
  42. 42.
    Muller-Felber W, Landgraf R, Scheuer R, Wagner S, Reimers CD, Nusser J, Abendroth D, Iiiner WD, Land W: Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 42: 1482–1486, 1993.PubMedCrossRefGoogle Scholar
  43. 43.
    Julian BA, Quarles LD, Niemann KM: Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 19: 99–120, 1992.PubMedGoogle Scholar
  44. 44.
    Sumrani NB, Daskalakis P, Miles AM, Sarkar S, Markell MS, Hong JH, Friedman EA, Sommer BG: Erythrocytosis after renal transplantation. A prospective analysis. ASAIO J 39: 51–55, 1993.PubMedGoogle Scholar
  45. 45.
    Landgraf R, Nusser J, Muller W, Landgraf-Leurs MM, Thurau S, Ulbig M, Kampik A, Lachenmayr B, Hillebrand G, Schleibner S: Fate of late complications in type I diabetic patients after successful pancrease kidney transplantation. Diabetes 38 (Suppl l): 33–37, 1989.PubMedGoogle Scholar
  46. 46.
    Larsen JL, Larson CE, Hirst K, Miller SA, Ozaki CF, Taylor RJ, Stratta RJ: Lipid status after combined pancreas-kidney transplantation and kidney transplantation alone in type I diabetes mellitus. Transplantation 54: 992–926, 1992.PubMedCrossRefGoogle Scholar
  47. 47.
    Ekstrand A, Groop L, Pettersson E, Gronhagen-Riska C, Laatikainen L, Matikainen E, Seppalainen AM, Laasonen E, Summanen P, Ollus A: Metabolic control and progression of complications in insulin-dependent diabetic patients after kidney transplantation. J Intern Med 232: 253–261, 1992.PubMedCrossRefGoogle Scholar
  48. 48.
    Laatikainen L, Summanen P, Ekstrand A, Groop L: Oph-thalmological follow-up of diabetic patients after kidney transplantation. Ger J Ophthalmol 2: 24–27, 1993.PubMedGoogle Scholar
  49. 49.
    Mauer SM, Goetz FC, McHugh LE, Sutherland DE, Barbosa J, Najarian JS, Steffes MW: Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes 38: 516–512, 1989.PubMedCrossRefGoogle Scholar
  50. 50.
    Osterby R, Nyberg G, Hedman L, Karlberg I, Persson H, Svalander C: Kidney transplantation in type 1 (insulin-dependent) diabetic patients. Early glomerulopathy. Diabetologia 34: 668–674, 1991.PubMedCrossRefGoogle Scholar
  51. 51.
    Barbosa J, Steffes MW, Sutherland DE, Connett JE, Rao KV, Mauer SM: Effect of glycemic control on early diabetic renal lesions. A 5 year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. JAMA 272: 600–606, 1994.PubMedCrossRefGoogle Scholar
  52. 52.
    Cheung AT, Cox KL, Ahlfors CE, Bry WI: Reversal of microangiopathy in long-term diabetic patients after successful simultaneous pancrease-kidney transplants. Transplant Proc 25: 1310–1333, 1993.PubMedGoogle Scholar
  53. 53.
    Pi-Sunyer FX: Medical hazards of obesity. Ann Intern Med 119: 655–660, 1993.PubMedCrossRefGoogle Scholar
  54. 54.
    Pirsch JD, Armbrust MJ, Knechtle SJ, D’Alesandro AM, Sollinger HW, Heisey DM, Beizer FO: Obesity as a risk factor following renal transplantation. Transplantation 59: 631–647, 1995.PubMedGoogle Scholar
  55. 55.
    Holley JL, Shapiro R, Lopatin WB, Tzakis AG, Hakala TR, Starzl TE: Obesity as a risk factor following cadaveric renal transplantation. Transplantation 49: 387–389, 1990.PubMedCrossRefGoogle Scholar
  56. 56.
    Terasaki PI, Koyama H, Cecka JM, Gjertson DW: The hyperfiltration hypothesis in human renal transplantation. Transplantation 57: 1450–1454, 1994.PubMedGoogle Scholar
  57. 57.
    Johnson CP, Gallagher-Lepak S, Zhu Y-R, Porth C, Kelber S, Roza AM, Adams MB: Factors influencing weight gain after renal transplantation. Transplantation 56: 822–827, 1993.PubMedCrossRefGoogle Scholar
  58. 58.
    Brown JH, Doherty CC: Renal replacement therapy in multiple myeloma and systemic amyloidosis. Postgrad Med J 69: 672–678, 1993.PubMedCrossRefGoogle Scholar
  59. 59.
    Kilicturgay S, Haberai M: Transplantation for renal amyloidosis. Ren Fail 15: 629–633, 1993.PubMedCrossRefGoogle Scholar
  60. 60.
    Isoniemi H, Eklund B, Hockerstedt K, Salmela K, Ahonen J: Renal transplantation in amyloidosis. Transplant Proc 21: 2039–2040, 1989.PubMedGoogle Scholar
  61. 61.
    Heering P, Kutkuhn B, Frenzel H, Linke RP, Grabensee B: Renal transplantation in amyloid nephropathy. Int Urol Nephrol 21: 339–347, 1989.PubMedCrossRefGoogle Scholar
  62. 62.
    Brown JH, Maxwell AP, Bruce T, Murphy RG, Doherty CC: Renal replacement therapy in multiple myeloma and systemic amyloidosis. Ir J Med Sei 162: 213–217, 1993.CrossRefGoogle Scholar
  63. 63.
    Kilicturgay S, Tokyay R, Arslan G, Rilgin N, Haberai M: The results of transplantation of patients with amyloid nephropathy. Transplant Proc 24: 1788–1789, 1992.PubMedGoogle Scholar
  64. 64.
    Shmueli D, Lustig S, Nakache R, Yussim A, Bar-Nathan N, Shaharahani F, Shapira Z: Renal transplantation in patients with amyloidosis due to familial Mediterranean fever. Transplant Proc 24: 1783–1784, 1992.PubMedGoogle Scholar
  65. 65.
    Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke TB, Flatmark A: Fifteen years’ experience with renal transplantation in systemic amyloidosis. Transplant Int 5: 15–18, 1992.CrossRefGoogle Scholar
  66. 66.
    Cohen SL, Boner G, Shmueli D, Yusim A, Rosenfeld J, Shapira Z: Cyclosporin: poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant 4: 201–204, 1989.PubMedGoogle Scholar
  67. 67.
    Zemer D, Livneh A, Pras M, Schar F: Familial Mediterranean fever in the colchicine era: the fate of one family. Am J Med Genet 45: 340–344, 1993.PubMedCrossRefGoogle Scholar
  68. 68.
    Livneh A, Zemer D, Siegal R, Laor A, Sohar F, Pras M: Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. Nephron 60: 418–422, 1992.PubMedCrossRefGoogle Scholar
  69. 69.
    Johnson WJ, Kyle RA, Pineda AA, O’Brien PC, Holley KE: Treatment of renal failure associated with multiple myeloma. Arch Intern Med 150: 863–869, 1990.PubMedCrossRefGoogle Scholar
  70. 70.
    David-Neto E, Ianhez LE, Chocair PR, Saldanha LB, Sabbaga E, Arap S: Renal transplantation in systemic light chain deposition (SLCD): a 44 month follow-up without recurrence. Transplant Proc 21: 2128–2129, 1989.PubMedGoogle Scholar
  71. 71.
    Alpers CE, Marchioro TL, Johnson RJ: Monoclonal immunoglobulin deposition disease in a renal allograft: probable recurrent disease in a patient without myeloma. Am J Kidney Dis 13:418–123, 1989.PubMedGoogle Scholar
  72. 72.
    Cosio FT, Pence TV, Shapiro FL, Kjellstrand: Severe renal failure in multiple myeloma. Clin Nephrol 15: 206–210, 1981.PubMedGoogle Scholar
  73. 73.
    Walker F, Bear RA: Renal transplantation in light chain multiple myeloma. Am J Nephrol 3: 34–37, 1983.PubMedCrossRefGoogle Scholar
  74. 74.
    Gerlag PGG, Koene RAP, Berden JHM: Renal transplantation in light chain nephropathy: case report and review of the literature. Clin Nephrol 25: 101–104, 1986.PubMedGoogle Scholar
  75. 75.
    Spence RK, Hill GS, Goldwein MI, Grossman RA, Barker CF, Perloff LJ: Renal transplantation for end-stage myeloma kidney. Arch Surg 114: 950–952, 1979.PubMedCrossRefGoogle Scholar
  76. 76.
    Humphrey RL, Wright JR, Zachary JB, Sterioff S, DeFronzo RA: Renal transplantation in multiple myeloma. Ann Intern Med 83: 651–653, 1975.PubMedCrossRefGoogle Scholar
  77. 77.
    De Lima JJG, Kourilsky O, Meyrier A, Morel-Maroger L, Sraer JD: Kidney transplantation in multiple myeloma. Transplantation 31: 223–224, 1981.PubMedCrossRefGoogle Scholar
  78. 78.
    Medical Staff Conference: The kidney in multiple myeloma. West J Med 129: 41–59, 1978.Google Scholar
  79. 79.
    Briefel GR, Spees EK, Humphrey RL, Hill GS, Sarai R, Zachary JB: Renal transplantation in a patient with multiple myeloma and light chain nephropathy. Surgery 93: 579, 1983.PubMedGoogle Scholar
  80. 80.
    Penn I: Kidney transplantation following treatment of tumors. Transplant Proc 18: 16–20, 1986.Google Scholar
  81. 81.
    Ingo N, Palmer AB, Severn A, Trafford JA, Mufti GH, Taube D, Parsons V: Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment. Q J Med 73: 903–910, 1989.Google Scholar
  82. 82.
    Iggo N, Parsons V: Renal disease in multiple myeloma: current perspectives. Nephron 56: 229–233, 1990.PubMedCrossRefGoogle Scholar
  83. 83.
    Coplon NS, Diskin CJ, Petersen J, Swenson RS: The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 308: 186–190, 1983.PubMedCrossRefGoogle Scholar
  84. 84.
    Ward LA, Jelveh Z, Feinfeld DA: Recurrent membranous lupus nephritis after renal transplantation: a case report and review of the literature. Am J Kidney Dis 23: 326–329, 1994.PubMedGoogle Scholar
  85. 85.
    Nyberg G, Blohme I, Persson H, Glausson M, Svalandar C: Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy. Nephrol Dial Transplant 7: 1116–1123, 1992.PubMedGoogle Scholar
  86. 86.
    Goss JA, Cole BR, Jandrisak MD, McCullough CS, So SK, Windus DW, Hanto DW: Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature. Transplantation 52: 805–810, 1991.PubMedCrossRefGoogle Scholar
  87. 87.
    Krishnan G, Tharker I, Angstadt JD, Canelli JP: Multicenter analysis of renal allograft survival in lupus patients. Transplant Proc 23: 1755–1756, 1991.PubMedGoogle Scholar
  88. 88.
    Nossant HC, Swaak TJ, Berden JH: Systemic lupus erythematosus after renal transplantation: patient and graft survival and disease activity. The Dutch Working Party on Systemic Lupus Erythematosus. Ann Intern Med 114:183-Google Scholar
  89. 89.
    Nyberg G, Karlberg I, Svalandar C, Hedman I, Blohme I: Renal transplantation in patients with systemic lupus erythematosus: increased risk of early graft loss. ScandJ Urol Nephrol 24: 307–313, 1990.Google Scholar
  90. 90.
    Rivera M, Mareen R, Pascual J, Naya MT, Orofino I, Ortuno J: Kidney transplantation in systemic lupus erythematosus nephritis: a one-center experience. Nephron 56: 148–151, 1990.PubMedCrossRefGoogle Scholar
  91. 91.
    Cheigh JS, Kim H, Stenzel KH, Tapia I, Sullivan JF, Stubenbord W, Riggin RR, Rubin AI: Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 16: 189–185, 1990.PubMedGoogle Scholar
  92. 92.
    Bitker MO, Barrou B, Qurhama S, Mouquet C, Chartier- Kastler E, Luciani J, Chatelain C: Renal transplantation in patients with systemic lupus erythematosus. Transplant Proc 25: 2172–2173, 1993.PubMedGoogle Scholar
  93. 93.
    Cheigh JS, Stenzel KH: End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis 21: 2–8, 1993.PubMedGoogle Scholar
  94. 94.
    Bumgardner GL, Mauer SM, Ascher NL, Payne WD, Dunn DL, Fryd DS, Sutherland DE, Simmons RL, Najarian JS: Long-term outcome of renal transplantation in patients with systemic lupus erythematosus. Transplant Proc 21: 2031–2032, 1989.PubMedGoogle Scholar
  95. 95.
    Sokunhi D, Wadhwa NK, Waltzer WD, Rapaport FT: Renal transplantation in patients with end-stage renal disease secondary to systemic lupus erythematosus. Transplant Proc 25: 3328–3333, 1993.Google Scholar
  96. 96.
    Padilla R, Pollak VF, Peace A, Kent KS, Gilinsky NH, Daddens JA: Pancreatitis in patients with end-stage renal disease. Medicine (Baltimore) 73: 8–20, 1994.Google Scholar
  97. 97.
    Conley CL, Hartman RC: A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31: 621–622, 1952.Google Scholar
  98. 98.
    Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19: 1181–1185, 1992.PubMedGoogle Scholar
  99. 99.
    Farrugia E, Tores VE, Gastineau D, Michet CJ, Holley KE: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 20:463-Google Scholar
  100. 100.
    Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F: Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 20: 150–158, 1992.PubMedGoogle Scholar
  101. 101.
    Radhakrishnan J, Williams GS, Appel BG, Cohen DJ: Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kidney Dis 23: 286–289, 1994.PubMedGoogle Scholar
  102. 102.
    Sitter T, Spannagl M, Schifft H: Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 65: 79–82, 1992.PubMedCrossRefGoogle Scholar
  103. 103.
    Pasquali S, Banfi G, Zucchelli A, Moroni, Ponticelli C, Zucchelli P: Lupus membranous nephropathy: long-term outcome. Clin Nephrol 39: 175–182, 1993.PubMedGoogle Scholar
  104. 104.
    Mareen R, Pascual J, Quereda C, Pardo A, Mampaso F, Orofino L, Teruel JL, Ortuno J: Lupus anticoagulant and thrombosis of kidney allograft vessels. Transplant Proc 22: 1396–1398, 1990.Google Scholar
  105. 105.
    Sturfelt G, Mousa F, Jonsson H, Nived O, Thysell H, Wollheim F: Recurrent cerebral infarction and the anti-phospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus. Ann Rheum Dis 49: 939–941, 1990.PubMedCrossRefGoogle Scholar
  106. 106.
    Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC: Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 46: 1–15, 1994.PubMedCrossRefGoogle Scholar
  107. 107.
    Jennette JC, Falk RJ: Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 15: 517–529, 1990.PubMedGoogle Scholar
  108. 108.
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosus: an analysis of 158 patients. Ann Intern Med 116: 488–998, 1992.PubMedCrossRefGoogle Scholar
  109. 109.
    Steinman TI, Jaffe BF, Monaco AP, Wolff SM, Fauci AS: Recurrence of Wegener’s granulomatosis after kidney transplantation. Successful reinduction of remission with cyclophosphamide. Am J Med 68:458–160,1980.Google Scholar
  110. 110.
    Curtis JJ, Diethelm AG, Herrera GA, Crowell WT, Whelchel JD: Recurrence of Wegener’s granulomatosis in a cadaver renal allograft. Transplantation 36: 452–454, 1983.PubMedCrossRefGoogle Scholar
  111. 111.
    Rosenstein ED, Ribot S, Ventresca E, Kramer N: Recurrence of Wegener’s granulomatosis following renal transplantation. Br J Rheumatol 33: 869–871, 1994.PubMedCrossRefGoogle Scholar
  112. 112.
    Boubenider SA, Akhtar M, Alfurayh O, Algazlan S, Taibah K, Qunibi W: Late recurrence of Wegener’s granulomatosis presenting as tracheal stenosis in a renal transplant patient. Clin Transplant 8: 5–9, 1994.PubMedGoogle Scholar
  113. 113.
    Rich LM, Piering WF: Ureteral stenosis due to recurrent Wegener’s granulomatosis after kidney transplantation. J Am Soc Nephrol 4: 1516–1521, 1994.PubMedGoogle Scholar
  114. 114.
    Kuross S, Davis T, Kjellstrand CM: Wegener’s granulomatosis with severe renal failure: clinical course and results of dialysis and transplantation. Clin Nephrol 16: 172–180, 1981.PubMedGoogle Scholar
  115. 115.
    Weiss JH, Bhathma DB, Curtis JJ, Lucas BA, Luke RG: A possible relationship between Henoch-Schonlein syndrome and IgA nephropathy. Nephron 22: 582, 1978.PubMedCrossRefGoogle Scholar
  116. 116.
    Mueldes Q, Pirson Y, Cosyns J-P, Squifflet J-P, van Ypersele de Strihou C: Course of Henoch-Schonlein nephritis after renal transplantation: report on ten patients and review of the literature. Transplantation 58: 1179–1186, 1994.Google Scholar
  117. 117.
    Montalbert C, Carvallo A, Broumand B, Noble D, Anstine LA, Currier CB: Successful renal transplantation in polyarteritis nodosa. Clin Nephrol 14: 206–209, 1980.PubMedGoogle Scholar
  118. 118.
    Wilson CB, Dixon FJ: AntiGBM antibody induced glomerulonephritis. Kidney Int 3: 74–89, 1973.PubMedCrossRefGoogle Scholar
  119. 119.
    Beieil OM, Coburn JW, Shinaberger JH, Glassrock RJ: Recurrent glomerulonephritis due to anti-glomerular basement membrane antibodies in two successive allografts. Clin Nephrol 1: 377–380, 1973.Google Scholar
  120. 120.
    Almkuist RD, Buckalew VM, Hirszel P, Mäher JF, James PM, Wilson CB: Recurrence of antiglomerular basement membrane antibody mediated glomerulonephritis in an isograft. Clin Immunol Immunopathol 18: 54, 1981.PubMedCrossRefGoogle Scholar
  121. 121.
    Lim EC, Terasaki PI: Outcome of kidney transplantation in different diseases. Clin Transplant 4: 461–469, 1990.Google Scholar
  122. 122.
    Harris PC, Ward CJ, Peral B, Hughes J: Polycystic kidney disease 1: identification and analysis of the primary defect. J Am Soc Nephrol 6 (4): 1125–1133, 1995.PubMedGoogle Scholar
  123. 123.
    Parfrey PS: Hereditary renal diseases. Curr Opin Nephrol Hypertens 2: 192–200, 1993.PubMedCrossRefGoogle Scholar
  124. 124.
    Lim EC, Terasaki PI: Outcome of renal transplantation in different primary diseases. Clin Transplant 5: 293–303, 1991.Google Scholar
  125. 125.
    Delaney V, Sumrani N, Butt KM, Hong JH: The impact of cyclosporin in patients with adult polycystic kidney disease following transplantation. Nephron 59: 537–542, 1991.PubMedCrossRefGoogle Scholar
  126. 126.
    Fitzpatrick PM, Torres VE, Charboneau JW, Offord KP, Holley KE, Zincke H: Long-term outcome of renal transplantation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 15: 536–543, 1990.Google Scholar
  127. 127.
    Jacobs C, Seiwood NH: Renal replacement therapy for end-stage renal failure in France: current status and evolutive trends over the last decade. Am J Kidney Dis 25: 188–195, 1995.PubMedCrossRefGoogle Scholar
  128. 128.
    Fenton S, Desmeules M, Copleston P, Arbus G, Froment D, Jeffrey J, Kjellstrand C: Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register. Am J Kidney Dis 25: 134–150, 1995.PubMedCrossRefGoogle Scholar
  129. 129.
    Disney APS: Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis 25: 165–175, 1995.PubMedCrossRefGoogle Scholar
  130. 130.
    Florijn KW, Chang PC, van der Woude FJ, van Bockel JH, van Saase JLCM: Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation 57: 73–81, 1994.PubMedCrossRefGoogle Scholar
  131. 131.
    Timio M, Monarca C, Pede S, Gentili S. Verdura C, Lolli S: The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10 year follow-up in a five-generation kindred. Clin Nephrol 37: 245–250, 1992.PubMedGoogle Scholar
  132. 132.
    Levey AS, Pauker SG, Kassirer JP: Occult intracranial aneurysms in polycystic kidney disease. N Engl J Med 308: 986–990, 1983.PubMedCrossRefGoogle Scholar
  133. 133.
    Abramson SJ, Berdon WE, Laffey K, Ruzal-Shapiro C, Nash M, Baer J: Colonic diverticulitis in young patients with chronic renal failure and transplantation. Pediatr Radiol 21: 352–354, 1991.PubMedCrossRefGoogle Scholar
  134. 134.
    Rayner BL, Cassidy MJ, Jacobsen JE, Pascoe MD, Pontin AR, van Zyl Smit R: Is preliminary binephrectomy necessary in patients with autosomal dominant polycystic kidney disease undergoing renal transplantation? Clin Nephrol 34: 122–124, 1990.PubMedGoogle Scholar
  135. 135.
    Warholm C, Rekola S, Roll M: Fatal outcome of bilateral nephrectomy in a patient with polycystic kidney disease. Scand J Urol Nephrol 26: 201–203, 1992.PubMedGoogle Scholar
  136. 136.
    Kashtan CE, Michael AF: Hereditary nephritis. Semin Nephrol 9: 135–146, 1989.PubMedGoogle Scholar
  137. 137.
    Knebelmann B, Antignac C, Gubler M-C, Grunfeld J-P: A molecular approach to inherited kidney disorders. Kidney Int 44: 1205–1216, 1993.PubMedCrossRefGoogle Scholar
  138. 138.
    Advisory Committee to the Renal Transplant Registry: Renal transplantation in congenital and metabolic diseases—a report from the ASC/NIH Renal Transplant Registry. JAMA 232: 148–153, 1975.CrossRefGoogle Scholar
  139. 139.
    Milliner DS, Pierdes AM, Holley KE: Renal transplantation in Alport’s syndrome. Anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57:35–13, 1987.Google Scholar
  140. 140.
    Peten E, Pirson Y, Cosyns JP, Squifflet JP, Alexandre GP, Noel LH, Grunfeld JP, van Ypersele de Strihou C: Outcome of thirty patients with Alport’s syndrome after renal transplantation. Transplantation 52: 823–826, 1991.PubMedCrossRefGoogle Scholar
  141. 141.
    Diaz JI, Valenzuela R, Gephardt G, Novick A, Tubbs RR: Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport’s syndrome. Arch Pathol Lab Med 118: 728–731, 1994.PubMedGoogle Scholar
  142. 142.
    Berardinelli L, Pozzoli E, Raiteri M, Canal R, Tonello G, Tarantino A, Vegeto A: Renal transplantation in Alport’s syndrome. Personal experience in twelve patients. Contrib Nephrol 80: 131–134, 1990.PubMedGoogle Scholar
  143. 143.
    Goldman M, Depierreux M, De Pauw L, Vereerstraeten P, Kinnaert P, Noel LH, Grunfeld JP, Toussaint C: Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport’s syndrome: case report and review of the literature. Transplant Int 3: 82–85, 1990.Google Scholar
  144. 144.
    Allon M: Renal abnormalities in sickle cell disease. Arch Intern Med 150: 501–510, 1990.PubMedCrossRefGoogle Scholar
  145. 145.
    Powars D, Elliott-Mills D, Chan L: Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115: 614–622, 1991.PubMedCrossRefGoogle Scholar
  146. 146.
    Tomson CR, Edmunds ME, Chambers K, Bricknell S, Feehally J, Walls J: Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle cell anemia and renal failure. Nephrol Dial Transplant 7: 817–821, 1992.PubMedGoogle Scholar
  147. 147.
    Powe NR, Griffiths RI, Greer JW, Watson AJ, Anderson GF, de Lissovoy G, Herbert RJ, Eggers PW, Milam RA, Whelton PK: Early dosing practices and effectiveness of recombinant human erythropoietin. Kidney Int 43: 1125–1133, 1993.PubMedCrossRefGoogle Scholar
  148. 148.
    Chatterjee SN: National study in natural history of renal allografts in sickle cell disease or trait: a second report. Transplant Proc 19: 33–35, 1987.PubMedGoogle Scholar
  149. 149.
    Montgomery R, Zibari G, Hill GS, Ratner LE: Renal transplantation in patients with sickle cell nephropathy. Transplantation 58: 618–642, 1994.PubMedCrossRefGoogle Scholar
  150. 150.
    Tomson CR: End stage renal disease in sickle cell disease: future directions. Postgrad Med J 68: 775–778, 1992.PubMedCrossRefGoogle Scholar
  151. 151.
    Spector D, Zachary JB, Sterioff S, Millan J: Painful crisis following renal transplantation in sickle cell anemia. Am J Med 64: 835–839, 1978.PubMedCrossRefGoogle Scholar
  152. 152.
    Miner DJ, Jorkasky DK, Perloff LJ, Grossman RA, Tomaszewski JE: Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis 10: 306–313, 1987.PubMedGoogle Scholar
  153. 153.
    Brennan DC, Lippmann BJ, Shenoy S, Lowell JA, Howard TK, Flye MW: Living unrelated renal transplantation for sickle cell nephropathy. Transplantation 59: 794–795, 1995.PubMedCrossRefGoogle Scholar
  154. 154.
    Williams HE, Smith LH: Primary hyperoxaluria. In: JB Stanbury, JB Wyngaarden, DS Fredrickson, eds, The Metabolic Basis of Inherited Disease. McGraw Hill, New York, pp 182–204, 1978.Google Scholar
  155. 155.
    Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH: Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331: 1553–1558, 1994.PubMedCrossRefGoogle Scholar
  156. 156.
    Cameron JS: Recurrent disease in renal allografts. Kidney Int Suppl 43: S91 - S94, 1993.PubMedGoogle Scholar
  157. 157.
    Katz A, Freese D, Danpura CJ, Scheinman JI, Mauer SM: Success of kidney transplantation in oxalosis is unrelated to residual hepatic enzyme activity. Kidney Int 42: 1408–1411, 1992.PubMedCrossRefGoogle Scholar
  158. 158.
    Scheinman JI, Namarian JS, Mauer SM: Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25: 804–811, 1984.PubMedCrossRefGoogle Scholar
  159. 159.
    Watts RWE, Roles K, Morgan SH: Successful treatment of primary hyperoxaluria type 1 by combined hepatic and renal transplantation. Lancet 2: 474–475, 1987.PubMedCrossRefGoogle Scholar
  160. 160.
    Lloveras J J, Durand D, Dopre C, Rischman P, Fourtanier G, Ton-That H, Suc JM: Combined liver kidney transplantation in primary hyperoxaluria type I. Prevention of the récidivé of calcium oxalate deposits in the renal graft. Clin Nephrol 38: 128–131, 1992.PubMedGoogle Scholar
  161. 161.
    Rodby RA, Tyszka TS, Williams JW: Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. Am J Med 90: 498–504, 1991.PubMedGoogle Scholar
  162. 162.
    Toussaint C, De Pauw L, Vienne A, Sevenois PA, Quintin J, Gelin M, Pasteeis JL: Radiological and histological improvement of oxalate osteopathy after combined liver-kidney transplantation in praimary hyperoxaluria type 1. Am J Kidney Dis 21: 54–63, 1993.PubMedGoogle Scholar
  163. 163.
    Scheinman JI: Primary hyperoxaluria: therapeutic strategies for the 90’s. Kidney Int 40: 389–399, 1991.PubMedCrossRefGoogle Scholar
  164. 164.
    Lloveras JJ, Dupre-Goudable C, Rey JP, Sporer P, Durand D, Ton-That H, Sue JM: The European experience of liver-kidney transplantation for primary hyperoxaluria type I. Prevention of recurrent intrarenal oxalate deposits. Presse Med 20: 2016–2018, 1991.PubMedGoogle Scholar
  165. 165.
    Watts RW, Danpure CJ, De Pauw L, Toussaint C: Combined liver-kidney and isolated liver transplantations for primary hyperoxaluria type 1: the European experience. The European study Group on Transplantation in Hyperoxaluria Type 1. Nephrol Dial Transplant 6: 502–511, 1991.PubMedCrossRefGoogle Scholar
  166. 166.
    Watts RW, Morgan Sh, Danpure CJ, Purkiss P, Calne RY, Rolles K, Baker LR, Mansell MA, Smith LH, Merion RM: Combined hepatic and renal transplantation in primary hyperoxaluria type I. Clinical report of nine cases. Am J Med 90: 179–188, 1991.PubMedGoogle Scholar
  167. 167.
    Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G: Kidney transplantation in primary oxalosis: data from the EDTA Registry. Nephrol Dial Transplant 5: 332–336, 1990.PubMedCrossRefGoogle Scholar
  168. 168.
    Ruder H, Otto G, Schutgens RB, Querfeld U, Wanders RJ, Herzog KH, Wolfel P, Pomer S, Scharer K, Rose GA: Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr 150: 56–58, 1990.PubMedCrossRefGoogle Scholar
  169. 169.
    dePauw L, Gelin M, Danpure CJ, Vereerstreeten P, Adler M, Abramowicz D, Toussaint C: Combined liver-kidney transplantation in primary hyperoxaluria type 1. Transplantation 50: 886–887, 1990.Google Scholar
  170. 170.
    Janssen F, Hall M, Schurmans T, De Pauw L, Hooghe L, Gelin M, Goyens P, Kinnaert P: Combined liver and kidney transplantation in primary hyperoxaluria type 1 in children. Transplant Proc 26: 110–111, 1994.PubMedGoogle Scholar
  171. 171.
    Shaked A, Thompson M, Wilkinson AH, Nuesse B, el Khoury GF, Rosenthal JT, Danovich GM, Busuttil RW: The role of combined liver/kidney transplantation in end-stage hepato-renal disease. Am Surg 59: 606–609, 1993.PubMedGoogle Scholar
  172. 172.
    Fauchald P, Flatmark A, Jellum E, Sodal G, Jorstad S: Combined hepatic and renal transplantation in primary hyperoxaluria type 1 (PHI): long-term results. Transplant Proc 26: 1799–1800, 1994.PubMedGoogle Scholar
  173. 173.
    Cochat P, Scharer K: Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1? Pediatr Nephrol 7: 326–327, 1993.CrossRefGoogle Scholar
  174. 174.
    Theodoropoulos DS, Krasnewich D, Kaiser Kupfer MI, Gahl WA: Classic nephropathic cystinosis as an adult disease. JAMA 270: 2200–2204, 1993.PubMedCrossRefGoogle Scholar
  175. 175.
    Markello TC, Bernardini IM, Gahl WA: Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328: 1157–1162, 1993.PubMedCrossRefGoogle Scholar
  176. 176.
    Almond PS, Matas AJ, Nakleh RE, Morel P, Troppmann C, Najarian JS, Chavers B: Renal transplantation for infantile cystinosis: long-term follow-up. J Pediatr Surg 28: 232–238, 1993.PubMedCrossRefGoogle Scholar
  177. 177.
    Ehrich JH, Brodehl J, Byrd DI, Hossfeld S, Hoyer PF, Leipert KP, Offner G, Wolff G: Renal transplantation in 22 children with nephropathic cystinosis. Pediatr Nephrol 5: 708–714, 1991.PubMedCrossRefGoogle Scholar
  178. 178.
    Offner G, Hoyer PF, Ehrich JH, Pichlmayr R, Brodehl J: Paediatric aspects of renal transplantation: experience of a single centre. Eur J Pediatr 151: S16 - S22, 1992.PubMedCrossRefGoogle Scholar
  179. 179.
    Charnas LR, Luciano CA, Dalakas M, Gilliatt RW, Bernardini I, Ishak K, Cwik VA, Fraker D, Brushart TA, Gahl WA: Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol 35: 181–188, 1994.PubMedCrossRefGoogle Scholar
  180. 180.
    Chik CL, Friedman A, Merriam GR, Gahl WA: Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med 119: 568–578, 1993.PubMedCrossRefGoogle Scholar
  181. 181.
    Winkler L, Offner G, Krull F, Brodehl J: Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 152: 244–249, 1993.PubMedCrossRefGoogle Scholar
  182. 182.
    Almond PS, Morel P, Troppmann C, Matas, Najarian JS, Chavers B: Progression of infantile cystinosis after renal transplantation. Transplant Proc 23: 1386, 1991.PubMedGoogle Scholar
  183. 183.
    Desnick RJ, Sweeley CC: Fabry’s disease: galactosidase deficiency. In: JB Stanbury, JB Wyngaarden, DS Fredickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw Hill, New York, pp 906–944, 1983.Google Scholar
  184. 184.
    Philippart M: Fabry disease: kidney transplantation on an enzyme replacement therapy. Birth Defects 9 (2): 81–87, 1973.PubMedGoogle Scholar
  185. 185.
    Desnick RJ, Allen KY, Simmons RL, Woods JE, Anderson CF, Najarian JS, Krivit W: Fabry disease: correction of the enzymatic deficiency by renal transplantation. Birth Defects 9 (2): 88–96, 1973.PubMedGoogle Scholar
  186. 186.
    Ramos EL: Recurrent diseases in the renal allograft. J Am Soc Nephrol 2: 109–121, 1991.PubMedGoogle Scholar
  187. 187.
    Maizel SE, Simmons RL, Kjellstrand C, Fryd DS: Ten year experience in renal transplantation in Fabry’s disease. Transplant Proc 13: 57–59, 1981.PubMedGoogle Scholar
  188. 188.
    Donati D, Novario R, Gastaldi L: Natural history and therapy of uremia secondary to Fabry’s disease: an European experience. Nephron 46: 353–360, 1983.CrossRefGoogle Scholar
  189. 189.
    Mosnier JF, Degott C, Bedorssian J, MOlas G, Degos F, Pruna A, Potet F: Recurrence of Fabry’s disease in a renal allograft eleven years after successful renal transplantation. Transplantation 51: 759–762, 1991.PubMedCrossRefGoogle Scholar
  190. 190.
    Schweitzer EJ, Drachenberg CB, Bartlett ST: Living kidney donor and recipient evaluation in Fabry’s disease. Transplantation 54: 924–927, 1992.PubMedCrossRefGoogle Scholar
  191. 191.
    Hoy WE, Megill DM: End-stage renal disease in southwestern Native Americans, with special focus on the Zuni and Navajo Indians. Tranplant Proc 21: 3906–3908, 1989.Google Scholar
  192. 192.
    Horina JH, Wirnsberger G, Horn S, Roob JM, Ratschek M, Holzer H, Pogglitsch H, Krejs GJ: Long-term follow-up of a patient with lecithin cholesterol acyltransferase deficiency syndrome after kidney transplantation. Transplantation 56: 233–236, 1993.PubMedCrossRefGoogle Scholar
  193. 193.
    Webb MC, Andrews PA, Koffman CG, Cameron JS: Renal transplantation in Wiskott-Aldrich syndrome. Transplantation 56: 1585, 1993.PubMedGoogle Scholar
  194. 194.
    Noblins M, Kleinknecht D, Dommergues JP, Nazaret C, Garay RP, Jullien M, Guillot M, Fries D, Charpentier B: Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases. Arch Fr Pediatr 49: 685–691, 1992.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Eleanor D. Lederer
    • 1
  1. 1.Kidney Disease ProgramUniversity of LouisvilleLouisvilleUSA

Personalised recommendations